Detalhe da pesquisa
1.
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study.
Blood;
140(7): 756-768, 2022 08 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35443031
2.
Allogeneic transplantation in acute myelogenous leukemia: a comprehensive single institution's experience.
Haematologica;
108(9): 2369-2379, 2023 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36951151
3.
Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis.
Ann Hematol;
102(4): 761-768, 2023 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36773040
4.
The transfusion of non-prophylactically RH-KEL1 antigen-matched red blood cells is feasible in selected myelodysplastic syndrome and acute myeloid leukaemia patients.
Vox Sang;
117(5): 693-700, 2022 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34985763
5.
Germline DDX41 mutations define a significant entity within adult MDS/AML patients.
Blood;
134(17): 1441-1444, 2019 10 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31484648
6.
IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria.
Blood;
141(25): 3122-3125, 2023 06 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37053552
7.
A landscape of germ line mutations in a cohort of inherited bone marrow failure patients.
Blood;
131(7): 717-732, 2018 02 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29146883
8.
Clinical, pathological, and molecular features of myelodysplasia cutis.
Blood;
139(8): 1251-1253, 2022 02 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34788403
9.
A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure.
Haematologica;
104(8): 1565-1571, 2019 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30733271
10.
Life-threatening complications and intensive care unit management in patients treated with blinatumomab for B-cell acute lymphoblastic leukemia.
Crit Care;
28(1): 14, 2024 01 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38183144
11.
Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies.
Haematologica;
102(4): 728-735, 2017 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28034993
12.
In vitro assessment of the sensitivity to APR-246 + azacitidine combination predicts response to this combination in myelodysplastic/acute myeloid leukaemia patients.
Br J Haematol;
194(4): e77-e79, 2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34145569
13.
Familial predisposition to TP53/complex karyotype MDS and leukemia in DNA repair-deficient xeroderma pigmentosum.
Blood;
133(25): 2718-2724, 2019 06 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30914417
14.
Azacitidine treatment for patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 3q abnormalities.
Am J Hematol;
90(10): 859-63, 2015 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26113240
15.
A phase II study of the efficacy and safety of an intensified schedule of azacytidine in intermediate-2 and high-risk patients with myelodysplastic syndromes: a study by the Groupe Francophone des Myelodysplasies (GFM).
Haematologica;
104(4): e131-e133, 2019 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30381302
16.
TSH restores a summer phenotype in photoinhibited mammals via the RF-amides RFRP3 and kisspeptin.
FASEB J;
27(7): 2677-86, 2013 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23538709
17.
Phase to phase: Navigating drug combinations with hypomethylating agents in higher-risk MDS trials for optimal outcomes.
Cancer Treat Rev;
123: 102673, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38176221
18.
Targeting a lineage-specific PI3KÉ£-Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader molecule.
Nat Cancer;
2024 May 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38816660
19.
Are myelodysplastic syndromes and acute myeloid leukaemia occurring during the course of lymphoma always therapy related?
Br J Haematol;
180(2): 304-308, 2018 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27662562
20.
Next-generation therapy for lower-risk MDS.
Hematology Am Soc Hematol Educ Program;
2023(1): 59-64, 2023 Dec 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38066862